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Abstract: 
Background: The frequency of prescribing potentially inappropriate 
medications (PIMs) in older patients remains high despite evidence of 
adverse outcomes from their use. Little is known about whether admission 
to hospital has any effect on appropriateness of prescribing.  
 
Objectives: This study aimed to identify the prevalence and nature of PIMs 
and explore the association of risk factors for receiving a PIM.  
 
Methods: This was a prospective study of 206 patients discharged to 
residential aged care facilities (RACFs) from acute care. All patients were 
aged at least 70 years and were admitted between July 2005 and May 
2010; their admission and discharge medications were evaluated.  
 
Results: Mean patient age was 84.8 ± 6.7 years; the majority (57%) were 
older than 85 years and mean (SD) Frailty Index was 0.42 (0.15).  At least 
one PIM was identified in 112 (54.4%) patients on admission and 102 
(49.5%) patients on discharge. Of all medications prescribed at admission 
(1728), 10.8% were PIMs and at discharge of 1759 medications, 9.6% 
were PIMs.  Of total 187 PIMs on admission, 56 (30%) were stopped and 
131 were continued; 32 new PIMs were introduced. Of the potential risk 
factors considered, in-hospital cognitive decline and frailty status were the 
only significant predictors of PIMs.  
 
Conclusion: Although, admission to hospital is an opportunity to review the 
indications for specific medications, a high prevalence of inappropriate drug 
use was observed. The only associations with PIM use were the frailty 
status and in-hospital cognitive decline. Additional studies are needed to 
further evaluate this association.  
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ABSTRACT 
 
Background: The frequency of prescribing potentially inappropriate medications (PIMs) in 
older patients remains high despite evidence of adverse outcomes from their use. Little is 
known about whether admission to hospital has any effect on appropriateness of prescribing. 
 
Objectives: This study aimed to identify the prevalence and nature of PIMs and explore the 
association of risk factors for receiving a PIM. 
 
Methods: This was a prospective study of 206 patients discharged to residential aged care 
facilities (RACFs) from acute care. All patients were aged at least 70 years and were admitted 
between July 2005 and May 2010; their admission and discharge medications were evaluated.  
 
Results: Mean patient age was 84.8 ± 6.7 years; the majority (57%) were older than 85 years 
and mean (SD) Frailty Index was 0.42 (0.15).  At least one PIM was identified in 112 
(54.4%) patients on admission and 102 (49.5%) patients on discharge. Of all medications 
prescribed at admission (1728), 10.8% were PIMs and at discharge of 1759 medications, 
9.6% were PIMs.  Of total 187 PIMs on admission, 56 (30%) ere stopped and 131 were 
continued; 32 new PIMs were introduced. Of the potential risk factors considered, in-hospital 
cognitive decline and frailty status were the only significant predictors of PIMs. 
 
Conclusion: Although, admission to hospital is an opportunity to review the indications for 
specific medications, a high prevalence of inappropriate drug use was observed. The only 
associations with PIM use were the frailty status and in-hospital cognitive decline. Additional 
studies are needed to further evaluate this association.  
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Introduction 
Our aging population, while a consequence of societal success, does present a challenge to 
the health care system. Older people are prescribed multiple medications and are more prone 
to adverse drug events (ADEs) that lead to increased mortality and morbidity and higher 
health care cost.
1-3
 The appropriate use of available pharmacotherapy requires consideration 
of both the benefits and risks of the medications. Drugs are classified as potentially 
inappropriate when the risks of treatment outweigh the benefits
4
; they are prescribed for 
longer periods than clinically indicated or without any clear indication; they are not 
prescribed when indicated
5
; and when they are likely to interact with other drugs and 
diseases.
6
 
 
Inappropriate prescribing in older patients can be detected using either explicit (criterion-
based) or implicit (judgment-based) screening tools.
7-9 
Explicit criteria are derived from 
expert reports or published reviews. They have high reliability and reproducibility but focus 
mainly on specific drugs and disease states. By contrast, implicit criteria are person-specific 
and explore patient preferences, rather than the disease and medications; they rely on 
evaluator judgment and tend to have low reliability and poor clinical utility.
10
 Although these 
criteria address some aspects of prescribing in older patients, they seldom consider the frailty 
of such patients. The omission of health status from established prescribing tools may help to 
explain the lack of clinical benefit from algorithm-based medication reviews.
3
 The Beers 
criteria are commonly used and they do measure some surrogates of frailty. They were 
originally developed in 1991 
11
 for use in the older nursing home population and have been 
subsequently updated in 1997, 2002 and 2012 so as to be applicable to all persons over 65 
years of age, regardless of their place of residence.
12-14
 The recently updated Beers criteria 
divide medications into three main categories according to major therapeutic classes and 
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organ systems: 34 medications are considered potentially inappropriate, independent of 
diagnosis, 14 are to be avoided in older adults with certain diseases and syndromes that can  
be exacerbated by the listed drug , while another 14 are to be used with caution in older 
adults.
14 
Although many medications on the Beers list are not available in Australia, use of 
these criteria for evaluation of prescribing has the advantage of enabling international 
comparison. 
 
Admission to hospital is an opportune time to review and rationalize prescribing, weighing up 
the benefits of pharmacotherapy against significant risks of polypharmacy and inappropriate 
prescribing in older adults, particularly those who are frail. However, little is known about 
whether admission to hospital has any effect on appropriateness of prescribing. Potentially 
inappropriate prescribing (PIP) is particularly common in long-term residents of aged care 
facilities; indeed institutionalization itself is an established independent risk factor for PIP.
15
 
Studies that have compared prevalence of potentially inappropriate medications (PIMs) at 
admission to hospital and discharge have reported inconsistent results. A prospective drug 
surveillance in an acute medical geriatric unit in France reported a decreased prevalence of 
PIMs from 66% at admission to 43.6% at discharge.
16
 A retrospective, non-randomised study 
in the Specialist Health and Ageing Unit in England, UK found a decreased prevalence from 
26.7% at admission to 22.6% at discharge.
17
 By contrast a similar study in Norway showed 
the increased prevalence of PIMs from 24% at admission to 35% at discharge.
18
 
 
Similar reports from Australian health care settings are limited and we cannot assume 
identical prevalence rates and PIM types in Australia due to the variations in health care 
systems and prescribing practices across countries. Therefore the main objective of this study 
was to determine the prevalence of PIP using the 2012 version of the American Geriatrics 
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Society (AGS) Beers Criteria in patients discharged from acute care to residential aged care 
facilities (RACFs). We also aimed to identify whether polypharmacy, age, gender, in-hospital 
falls, delirium, functional and cognitive decline and the frailty status of patients were 
independent risk factors for receiving an inappropriate medication.  
 
Methods 
Study population: This is a prospective study of patients, aged 70 and older, who were 
discharged to RACFs (206 out of total 1418 patients) following admission to 11 acute care 
hospitals in Queensland and Victoria, Australia. The sites ranged from small secondary care 
centres (with 120 – 160 beds, n = 2), through rural hospitals (250 – 280 beds, n = 2) to 
metropolitan teaching facilities (300 – 450 beds, n = 4) and major tertiary referral centres 
(>650 beds; n = 3).  All patients were admitted to the acute care hospitals between July 2005 
and May 2010. Patient recruitment has been described in detail elsewhere.
19, 20
 Patients were 
excluded if they were admitted to coronary or intensive care units, for terminal care only or 
were discharged from hospital within 24 hours. Only those patients entering RACFs at 
discharge were included in the study.  
 
Data collection and measurement tools: The interRAI Acute Care assessment tool was used 
for data collection.
21
 It has been specifically developed for use in the acute setting, to support 
Comprehensive Geriatric Assessment (CGA) for older inpatients.
22, 23
 This instrument screens 
a large number of domains around socio-demographic information, physical, cognitive and 
psycho-social functioning, medications, medical diagnoses, advance directives, and discharge 
destination.
23 
Trained nurse assessors gathered data at admission (within 24 hours in the 
ward) and at discharge.  A number of scales are embedded within the interRAI instruments 
combine single items belonging to domains such as activities of daily living (ADL), 
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instrumental activities of daily living (IADL) and cognition, which are used to describe the 
presence and extent of deficits in these domains.
22 
For each patient, all prescribed medication, 
including Anatomical Therapeutic Classification (ATC) codes, was recorded on admission 
and at discharge. Data were entered by pharmacists or pharmacy students and verified by a 
second pharmacist or geriatrician. 
 
Deriving a Frailty Index: A Frailty index (FI), an index of accumulated deficits, was 
calculated for each individual at admission using a well-defined methodology.
24
 Data 
collected using the interRAI assessment tool was coded as deficits. For example, in the 
domain of cognition, an acute change in mental status is recorded as a dichotomous, yes/ no 
response and this was coded as deficit present (1 point) or absent (0 points). Other data were 
recorded on an ordinal scale with cut-offs for 0/ 0.5/1 deficit coded according to the 
distribution of the data. For example, the domain of vision classified into four categories (0: 
adequate, 1: minimal difficulty, 2: moderate difficulty, 3: severe difficulty, 4: no vision) is 
coded with cut-offs of 0/0.5/1 (i.e. 0 = 0, 1 = 0.5, 2-4 = 1).Deficits crossed the domains of 
function, cognition, mood and behaviour, disease diagnoses and sensory impairments. 
Medication use was excluded from the FI. Each individual’s deficit points were then summed 
and divided by the total number of deficits considered (here, 52). For example, someone with 
6 deficits out of 40 counted has a FI of 0.15. The FI has a potential score of 0-1, where 0= 
absence of all deficits, and 1= all deficits present.
25
 Although the FI can be considered as a 
continuous variable with higher values representing greater frailty, 0.25 has been proposed as 
the cut-off between ‘fit’ and ‘frail’ individuals.
26
 
 
Polypharmacy: Polypharmacy was categorised into three groups based on the number of 
drugs in use. Hyper polypharmacy was defined as concurrent use of ten or more drugs; 
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polypharmacy was defined as use of five to nine drugs and non-polypharmacy represented 
patients using four or less drugs concomitantly. These cut-off points have been selected based 
on previous studies relating the risk of adverse outcomes in older people to numbers of 
prescribed medication.
27, 28
 
 
Covariates 
Fall in hospital: In-hospital fall was defined as having at least one fall during the period of 
hospitalization. These data were collected prospectively by daily chartreviews and ward visits 
by the research nurses using allavailable sources of information (interviewing the patientand 
medical staff, reviewing the medical records, andchecking the forms or systems for recording 
adverseevents).
29
 The process of data collection was based on thedetailed instructions 
provided in the tool manual.
21
 
 
Delirium in hospital: As part of the interRAI AC, varying mental function and acute changes 
in mental status from baseline was assessed by nurse assessor at admission and discharge. 
The two items were combined to screen for delirium. 
30
 Delirium in hospital was recorded if 
delirium screened positive at the admission or discharge assessments or if noted in the 
hospital records on daily ward visits by the nurse assessor.  
 
Failure to improve in ADL: Failure in improvement of ADL was assessed using change in the 
ADL short form scale that consists of four items (personal hygiene, walking, toilet use, and 
eating). Scores on the ADL scale range from 0 to 16, with higher scores indicating greater 
impairment.
20
 Failure to improve in ADL was defined as those with some ADL impairment 
on admission who had the same or worse (higher) ADL score on discharge compared to 
admission or who developed a new ADL impairment in hospital.  
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In-hospital cognitive function decline: The Cognitive Performance Scale (CPS) was used to 
measure cognitive impairment.
20
 Score ranges from ‘0’ to ‘6’with higher scores indicating 
greater impairment. In-hospital cognitive decline was defined as having a worse CPS score 
on discharge compared to admission.  
 
Statistical analysis: Data were analysed using the Statistical Package for the Social Sciences 
21.0 (IBM SPSS Statistics 21.Ink). A paired sample t-test was used to observe the 
relationship between admission and discharge medications. Standard multiple regression was 
used to detect risk factors for PIMs at both admission and discharge. Age, gender, number of 
admission and discharge medications, in-hospital falls, delirium, functional and cognitive 
decline and frailty index of patients were used as predictive variables for PIMs. A p-value of 
0.05 was considered statistically significant.  
 
Ethics: Ethics approval was obtained from the human research and ethics committee of each 
participating hospitals and The University of Queensland Medical Research Ethics 
Committee. All patients or their substitute decision-maker gave informed consent for 
participation. 
 
Results 
Patient characteristics: Of the 206 patients discharged to RACFs, 142 (69%) were female.  
The principal characteristics of the study population are described in Table 1. They had a 
mean (SD) age of 84.8 (6.8) years; the majority (57%) were older than 85 years and mean 
(SD) Frailty Index was 0.42 (0.15).A total of 35%were admitted from the community and 
65% from RACFs. The median length of stay in hospital was eight days. Of those discharged 
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to RACFs, approximately 60% were discharged to high care (a high level care setting for 
older people with 24-hour nursing care) and remaining 40% discharged to low care (residents 
require accommodation and personal care type services, but not 24-hour nursing care). 
 
General prescribing pattern: The number of medications prescribed on admission and 
discharge is shown in Table 2. Patients were prescribed a mean of 7.2 (±3.81) regular 
medications at admission and 8.1 (±3.95) on discharge to RACF. Comparing medication 
regimes at admission and discharge, the prevalence of polypharmacy was stable [106 (51.5%) 
vs 102 (49.5%) respectively] but with an increase in hyper-polypharmacy [from 50 patients 
(24.3%) to 67 (32.5%)]. 
 
At admission, two patients were prescribed 23 medications with 10 patients receiving at least 
20 medications. On discharge one (different to admission) patient was prescribed 23 
medications and four patients had at least 20 medications.At discharge, aspirin and anti-
platelet agents were the most frequently prescribed medications (109, 54%), followed by anti-
ulcer drugs in 105 (52%) patients.  Other prevalent medication included antidepressants 
(28.2%), benzodiazepines (19.3%), antipsychotics (16.3%) and opioids (16.3%). Of the 
potential risk factors, frailty status and in-hospital cognitive decline were the only significant 
predictors of PIMs at both admission (p= 0.047) and discharge (p = 0.032). However, no 
association was observed between PIM use, polypharmacy categories, age, gender, in-
hospital falls, delirium and functional decline.  
 
Potentially inappropriate medications at admission: On admission, 112 (54%) patients were 
on at least one PIM; 5 patients were on 4 PIMs. Of the 1460 regular medications prescribed at 
admission 187 (12.8%) were PIMs. Of these, 149 (80%) were classified as PIMs for older 
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people independent of diagnosis and 38 (20%) PIMs contraindicated in older people with 
certain diseases or syndromes (Table 3).  PIMs to be used with caution accounted for 3.8% of 
total medications prescribed. Commonly prescribed PIM categories were central nervous, 
cardiovascular and gastrointestinal system drugs, and analgesics. Multiple regression analysis 
revealed that frailty status was significantly associated to PIMs at admission [(p<0.05 OR= -
1.01 (-2.01, -0.01)]. Age, gender and number of admission medications were not associated 
with being prescribed PIMs.  
 
Potentially inappropriate medications at discharge: At discharge, 102 (49.5%) patients were 
on at least one PIM; one patient was discharged on 7 PIMs, 5 patients on 4 PIMs and 8 
patients on 3. Of all the 1652 regular medications prescribed at discharge, 168 (10.1%) were 
PIMs. Of these 168, 129 (77%) were classified as PIMs for older people independent of 
diagnosis and 39 (23%) of PIMs contraindicated in older people with certain diseases or 
syndromes (Table 3). PIMs to be used with caution accounted for 3.7% of total medications 
prescribed. Commonly prescribed PIMs categories were Central Nervous system (CNS) 
drugs, cardiovascular, gastrointestinal, respiratory medications, analgesics and 
antimuscarinics. Multiple regression analysis showed that only frailty status was a predictor 
of the number of PIMs at discharge [(p<0.05, OR= -2.15, -0.10)].  
 
Changes in potentially inappropriate medication between admission and discharge: Table 4 
shows the number of patients with total PIMs at admission and discharge.  Of the 187 PIMs 
prescribed at admission, 56 (30%) were stopped and 131 (70%) were continued while 32 new 
PIMs were started. PIMs introduced included CNS drugs [benzodiazepines (14/32), 
antipsychotics (8/32), and antidepressants (1/32)], respiratory medications (3/32), 
antiarrhythmics (2/32), gastrointestinal (2/32) and analgesics (2/32).  
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Discussion  
The present study demonstrated frequent use of inappropriate medications in older people 
discharged from acute care hospitals to RACFs. 54.4% of patients were on at least one PIM at 
admission to hospital with a non-significant trend to fewer PIMs on discharge (49.5%). The 
frailty status of patients and in-hospital cognitive decline were the only significant predictors 
for receiving PIMs at both admission and discharge. To our knowledge, this is the first study 
to identify this association.  
 
The prevalence of PIMs observed in this study population differ from those of previous 
studies using the recent updated 2012 Beers criteria. A higher prevalence (82.6%) was 
observed in a Brazilian long term care home study 
31
 and around 66% was observed in an 
Argentinian geriatric hospital.
32
 Yet a very low prevalence (16% and 25.5%) was noticed in 
tertiary health care setting in India and Nigeria respectively.
33, 34
 Commonly prescribed PIM 
categories at both admission and discharge were CNS, cardiovascular, gastrointestinal and 
respiratory drugs, and analgesics which are similar to those reported in other studies.
35-38
  Of 
note, 30% of PIMs were stopped and other new PIMs were introduced at discharge. We 
found a clear association between the use of PIMs, frailty status and cognitive decline of 
patients at admission and discharge. However, no association as observed between PIM 
use, age and gender, which is consistent with previous reports.
39, 40
 Also, no association of 
PIM use with in-hospital falls, delirium and functional decline was observed.  Furthermore, in 
contrast to other studies, 
41-44
 we found no association between polypharmacy and PIM use. 
 
There are a number of limitations to this study. Although patients were recruited from 
multiple hospital sites, the sample size is relatively small .The recently updated Beers criteria 
contain medications which are either not available in Australia (e.g. carisoprodol and 
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trimethobenzamide) or which have been withdrawn from use here (chlorpropamide, reserpine 
and phenylbutazone). Thus, the relevance of the tool within Australia could be questioned.
5
   
Moreover, these criteria also fail to address other issues such as drug duplication, under-
prescribing, and drug-drug interaction.
14, 45-47
 Hence, the prevalence of PIMs may be higher 
than those reported in this study. However, this study demonstrated the prevalence of PIMs in 
frail older patients on admission and discharge and adds to existing research by identifying 
patient’s frailty status as a unique risk factor associated with the use of PIMs.  
 
These discrepancies in Beers and other established criteria should be addressed either by 
developing new criteria or by refining the existing tools to make them more applicable to frail 
older people. The first and foremost step is to identify the frail patient in clinical practice by 
applying clinically validated tools (e.g. frailty index). Once the frail patient has been 
identified, there is a need for specific measures or criteria to assess appropriateness of therapy 
that consider such factors as quality of life, functional status and remaining life expectancy 
and thus modified goals of care.
48
 
 
Conclusion 
A high prevalence of potentially inappropriate drug prescribing was observed in older 
patients on admission to acute care hospitals and on discharge to RACFs. Frailty status and 
in-hospital cognitive decline of patients were risk factors for the use of PIMs.  The findings 
of this study provide a basis for designing interventions to rationalize prescribing in older 
patients. Further studies in different settings with larger population are warranted to evaluate 
the prevalence of potentially inappropriate medications and deviations in prescribing 
practices.  
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Table 1: Characteristics of study population 
Characteristics Value  
Age distribution  
                    Mean age [SD] 84.8 [6.8] 
                    65-74 years 20 [10] 
                   75-84 years 69 [33] 
>85 years 117 [57] 
Sex (n [%])  
                   Female 142 [69] 
                   Male 64 [31] 
Admitted from (n [%])  
                  Community 73 [35.4] 
                  RACF low care 64 [31.1] 
                  RACF high care 69 [33.5] 
Discharged to(n [%])  
                 RACF low care 81 [39.3] 
                 RACF high care 125 [60.7] 
Length of stay (days)  
                 Median length of stay (days [IQR])  8 [4-16] 
Frailty Index  
                 Mean (SD) 0.42 (0.15) 
IQR: Interquartile range 
 
 
 
Page 16 of 24
http://mc.manuscriptcentral.com/aop
The Annals of Pharmacotherapy
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
16 
 
Table 2: Number of regular medications prescribed on admission and discharge 
Medication category Admission N [%] Discharge N [%] 
Mean (SD) 7.2 [3.81] 8.1 [3.95] 
0 - 4 medications (non-polypharmacy) 47 [22.8] 35 [17.0] 
5-9 medications (polpharmacy) 106 [51.5] 102 [49.5] 
≥10 medications (excessive polypharmacy) 50 [24.3] 67 [32.5] 
Missing 3 [1.5] 2 [1.0] 
Total 1460 1652 
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Table 3: Potentially inappropriate medications (PIMs) on admission and discharge as determined by Beers criteria 
TCAs (Tricyclic antidepressants):  SSRIs (Selective Serotonin Reuptake Inhibitors): SNRIs (Selective Norepinephrine Reuptake Inhibitors) 
PIMs independent of medical condition PIMs in the presence of certain pathologies PIMs to be used with caution 
 Admissio
n 
Discharge  Admissio
n 
Discharge  Admissio
n 
Discharge 
System/therapeutic 
category/drugs 
N % N  % System/therapeuti
c category/drugs 
N % N % System/therapeuti
c category/drugs 
N % N % 
Central Nervous 
System 
10
6 
71.1 10
2 
79 Central Nervous 
System 
11 29.9 10 25.6 Antipsychotics 14 25.5 15 24.6 
Antidepressants 9 6 8 6.2 Antidepressants 2 5.3 2 5.1 SNRIs 3 5.5 4 6.5 
Antipsychotics 50 33.6 40 31 Antipsychotics 9 23.7 8 20.5 SSRIs 31 56.3 35 57.4 
Cardiovascular 47 31.5 54 41.8 Cardiovascular 12 31.5 9 23 TCAs 7 12.7 7 11.5 
Alpha blockers 4 2.7 4 3.1 Gastrointestinal 8 21 10 25.6      
Antiarrhythmic 14 9.4 7 5.4 Respiratory 5 13.1 8 20.5      
Gastrointestinal 23 15.5 12 9.3 Antimuscarinics 2 5.2 2 5.1      
Analgesics 2 1.4 4 3.1           
Total 14
9 
100 12
9 
100  38 100 39 100  55 100 61 100 
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Table 4: Potentially inappropriate medication distribution at admission and discharge  
 
Number of PIMs Number of patients (%) 
n= 206 
Admission Discharge 
 
No PIMs 94 (45.6) 104 (50.5) 
One PIM 60 (29.1) 59 (28.6) 
Two PIMs 34 (16.5) 29 (14.1) 
Three PIMs 13 (6.3) 8 (3.9) 
Four or more PIMs 5 (2.4) 6 (2.9) 
Total number of patients with at least one PIM 112 (54.4)  102 (49.5)  
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